Campora E - Search Results

1

The impact of chemotherapy on the quality of life of breast cancer patients.

Campora E, Naso C, Vitullo MT, Giudici S, Camoirano A, Repetto L, Rosso R. Campora E, et al. J Chemother. 1992 Feb;4(1):59-63. doi: 10.1080/1120009x.1992.11739141. J Chemother. 1992. PMID: 1383437

2

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.

Repetto L, Miglietta L, Gardin G, Naso C, Giudici S, Merlini L, Queirolo P, Campora E, Pronzato P, Rosso R. Repetto L, et al. Among authors: campora e. Ann Oncol. 1992 Feb;3(2):165-6. doi: 10.1093/oxfordjournals.annonc.a058135. Ann Oncol. 1992. PMID: 1606088 Free article.

3

Ifosfamide and etoposide salvage treatment in advanced ovarian cancer.

Bruzzone M, Campora E, Merlini L, Giudici S, Bottero G, Iskra L, Donadio M, Ferrari I, Ragni N. Bruzzone M, et al. Among authors: campora e. J Chemother. 1991 Oct;3(5):332-4. doi: 10.1080/1120009x.1991.11739115. J Chemother. 1991. PMID: 1809812

4

Tamoxifen and alpha interferon in advanced breast cancer.

Miglietta L, Repetto L, Gardin G, Amoroso D, Giudici S, Naso C, Merlini L, Queirolo P, Campora E, Pronzato P, et al. Miglietta L, et al. Among authors: campora e. J Chemother. 1991 Dec;3(6):383-6. doi: 10.1080/1120009x.1991.11739125. J Chemother. 1991. PMID: 1819622

5

Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.

Campora E, Baldini E, Rubagotti A, Chiara S, Bruzzi P, Sertoli MR, Rosso R. Campora E, et al. J Chemother. 1990 Oct;2(5):336-9. doi: 10.1080/1120009x.1990.11739039. J Chemother. 1990. PMID: 2090773 Clinical Trial.

6

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer.

Gardin G, Alama A, Rosso R, Campora E, Repetto L, Pronzato P, Merlini L, Naso C, Camoriano A, Meazza R, et al. Gardin G, et al. Among authors: campora e. Breast Cancer Res Treat. 1994;32(3):311-8. doi: 10.1007/BF00666008. Breast Cancer Res Treat. 1994. PMID: 7865857

7

Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.

Repetto L, Miglietta L, Gardin G, Lanfranco C, Naso C, Merlini L, Giudici S, Venturino A, Campora E, Testore F, et al. Repetto L, et al. Among authors: campora e. Breast Cancer Res Treat. 1994;30(2):133-7. doi: 10.1007/BF00666056. Breast Cancer Res Treat. 1994. PMID: 7949211 Clinical Trial.

8

[Tropisetron versus ondansetron in the prevention and control of emesis in patients undergoing chemotherapy with FAC/FEC for metastatic or surgically treated breast carcinoma].

Campora E, Simoni C, Rosso R. Campora E, et al. Minerva Med. 1994 Jan-Feb;85(1-2):25-31. Minerva Med. 1994. PMID: 8152575 Clinical Trial. Italian.

9

Mitoxantrone in elderly women with advanced breast cancer: a phase II study.

Repetto L, Simoni C, Venturino A, Biancardi V, Gasco M, Campora E, Rosso R. Repetto L, et al. Among authors: campora e. Anticancer Res. 1995 Sep-Oct;15(5B):2297-300. Anticancer Res. 1995. PMID: 8572641 Clinical Trial.

10

Vinorelbine as palliative therapy in advanced breast cancer.

Gasco M, Gardin G, Repetto L, Campora E, Rosso R. Gasco M, et al. Among authors: campora e. Anticancer Res. 1997 Mar-Apr;17(2B):1431-3. Anticancer Res. 1997. PMID: 9137510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters